CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 31, 2025	Apr. 30, 2025
Current assets:
Cash and cash equivalents	$ 8,516	$ 9,785
Accounts receivable, net	11,539	11,204
Prepaid expenses and other current assets	1,277	1,369
Total current assets	21,332	22,358
Operating lease right-of-use assets, net	4,348	5,080
Property and equipment, net	3,951	4,375
Other long-term assets	196	196
Goodwill	335	335
Total assets	30,162	32,344
Current liabilities:
Accounts payable	5,993	4,248
Accrued liabilities	2,188	2,556
Current portion of operating lease liabilities	1,525	1,471
Other current liability	97	135
Deferred revenue	12,338	15,443
Total current liabilities	22,141	23,853
Non-current operating lease liabilities	3,744	4,634
Other non-current liabilities	46	85
Total liabilities	25,931	28,572
Stockholders’ equity:
Common stock, $.001 par value; 200,000,000 shares authorized; 14,006,659 and 13,897,503 shares issued; and 13,886,326 and 13,777,170 outstanding as of July 31, 2025 and April 30, 2025, respectively	14	14
Treasury stock, at cost	(708)	(708)
Additional paid-in capital	84,985	84,358
Accumulated deficit	(80,121)	(79,892)
Total stockholders’ equity attributable to Champions Oncology, Inc.	4,170	3,772
Noncontrolling interest	61	0
Total stockholders' equity	4,231	3,772
Total liabilities and stockholders’ equity	$ 30,162	$ 32,344